Compare GRDN & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRDN | NEOG |
|---|---|---|
| Founded | 2004 | 1981 |
| Country | United States | United States |
| Employees | 3600 | N/A |
| Industry | Retail-Drug Stores and Proprietary Stores | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 1.9B |
| IPO Year | N/A | 1995 |
| Metric | GRDN | NEOG |
|---|---|---|
| Price | $36.89 | $9.29 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 4 |
| Target Price | ★ $40.60 | $10.67 |
| AVG Volume (30 Days) | 321.8K | ★ 2.6M |
| Earning Date | 05-06-2026 | 04-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $894,661,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $7.63 | N/A |
| P/E Ratio | ★ $117.77 | $466.25 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $19.17 | $4.53 |
| 52 Week High | $41.36 | $11.43 |
| Indicator | GRDN | NEOG |
|---|---|---|
| Relative Strength Index (RSI) | 50.86 | 48.33 |
| Support Level | $35.56 | $8.98 |
| Resistance Level | $37.78 | $10.12 |
| Average True Range (ATR) | 1.37 | 0.36 |
| MACD | -0.20 | -0.01 |
| Stochastic Oscillator | 39.16 | 37.24 |
Guardian Pharmacy Services Inc is a pharmacy services company providing technology-enabled services to help residents of long-term health care facilities (LTCFs) adhere to appropriate drug regimens, reducing the cost of care and improving clinical outcomes. The Company provides high-touch clinical, drug dispensing, and administration services tailored to residents in assisted living facilities, behavioral health facilities, and group homes, while also serving residents in all types of LTCFs. It partners with residents, LTCFs, and health plan payors to help reduce errors in drug administration, manage drug regimens, and improve adherence. The Company derives its revenue mainly from the sale of pharmaceutical and medical products.
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.